SCHEMBL6949451

SCHEMBL6949451

CCCOc1ccccc1N/C=C1\C(=O)N(c2ccccc2)N=C1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.50
FNTA P49354 1/20 0.48
FNTB P49356 1/20 0.48
KMT2A Q03164 12/20 0.48
L3MBTL1 Q9Y468 7/20 0.48
KDM4E B2RXH2 5/20 0.47
MAPT P10636 7/20 0.46
MAPK1 P28482 6/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
POLB P06746 3/20 0.45
ALDH1A1 P00352 5/20 0.45
TDP1 Q9NUW8 4/20 0.45
HTT P42858 3/20 0.45
LMNA P02545 2/20 0.45
MEN1 O00255 7/20 0.44
PKM P14618 2/20 0.44
HPGD P15428 2/20 0.44
HSP90AA1 P07900 1/20 0.44
MDM4 O15151 1/20 0.42
MDM2 Q00987 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6949454 1.00 GAA (0.50) GAAFNTAFNTBKMT2AL3MBTL1
SCHEMBL6950144 0.91 FNTA (0.56) GAAFNTAFNTBKMT2AL3MBTL1
SCHEMBL6950148 0.91 FNTA (0.56) GAAFNTAFNTBKMT2AL3MBTL1
SCHEMBL8427629 0.87 FNTA (0.45) GAAFNTAFNTBKMT2AL3MBTL1
SCHEMBL8427624 0.86 FNTA (0.51) GAAFNTAFNTBKMT2AL3MBTL1
SCHEMBL8427626 0.86 FNTA (0.51) GAAFNTAFNTBKMT2AL3MBTL1
SCHEMBL9525776 0.86 ALDH1A1 (0.53) GAAFNTAFNTBKMT2AL3MBTL1
SCHEMBL8011329 0.85 GAA (0.65) GAAKMT2AL3MBTL1KDM4EMAPT
SCHEMBL6945888 0.85 GAA (0.65) GAAKMT2AL3MBTL1KDM4EMAPT
SCHEMBL6947863 0.80 KDM4E (0.57) GAAKMT2AL3MBTL1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0743304-B1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GMBH (DE) 2003-03-26 EP disclosed
US-6034099-A Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones CELL PATHWAYS, INC. (US) 2000-03-07 US disclosed
EP-0930881-A1 PYRAZOLINONES TO TREAT DISTURBANCES OF POTENCY MERCK PATENT GmbH (DE) 1999-07-28 EP disclosed
US-5869516-A 4-(arylaminomethylene)-2,4-dihydro-3-pyrazolones MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1999-02-09 US disclosed
WO-1998016224-A1 PYRAZOLINONES TO TREAT DISTURBANCES OF POTENCY MERCK PATENT GMBH (DE) 1998-04-23 WO disclosed
EP-0743304-A1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GmbH (DE) 1996-11-20 EP disclosed